edoc

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab : a cross-sectional and longitudinal study

Jilek, Samantha and Jaquiéry, Emilie and Hirsch, Hans H. and Lysandropoulos, Andreas and Canales, Mathieu and Guignard, Laurence and Schluep, Myriam and Pantaleo, Giuseppe and Du Pasquier, Renaud A.. (2010) Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab : a cross-sectional and longitudinal study. The Lancet neurology, Vol. 9, H. 3. pp. 264-272.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6004444

Downloads: Statistics Overview

Abstract

Natalizumab is used to prevent relapses and progression of disability in patients with multiple sclerosis but has been associated with progressive multifocal leukoencephalopathy (PML). We aimed to better understand the associations between JC virus, which causes PML, and natalizumab treatment.
Faculties and Departments:03 Faculty of Medicine > Departement Biomedizin > Division of Medical Microbiology > Transplantation Virology (Hirsch)
UniBasel Contributors:Hirsch, Hans H.
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Elsevier
ISSN:1474-4465
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:24 May 2013 09:22
Deposited On:24 May 2013 09:05

Repository Staff Only: item control page